Sevelamer Carbonate Tablet, Film Coated
Product Images NDC 65162-058

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 65162-058). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Sevelamer Carbonate Tablets 1)

Chemical structure diagram illustrating the molecular components of Sevelamer Carbonate, the active ingredient in the film-coated tablet. The image shows part of the polymeric chain with ammonium (NH3+), bicarbonate (HCO3-), amino (NH2), and hydroxyl (OH) groups, representing the compound's complex chemical composition.*

FDA Label Image

2 (Sevelamer Carbonate Tablets 2)

A forest plot showing subgroup analyses of the LS Mean difference between Sevelamer Carbonate and placebo. Subgroups include Screening BSA, Baseline Serum Phosphorus, Age, and Dialysis status. Data points with confidence intervals illustrate treatment effects favoring Sevelamer Carbonate or placebo, with numerical summary statistics on the right.*

FDA Label Image

F-2 (Sevelamer Carbonate Tablets 3)

A line graph comparing the percentage of patients achieving at least a 1 mg/dL reduction in serum phosphorus. The x-axis represents the reduction in serum phosphorus (mg/dL) from -4 to 8, with labels indicating worsened increase and improved reduction from baseline. The y-axis shows the percentage of patients from 0% to 100%. Two lines are shown, labeled Sevelamer Hydrochloride and Active Control, tracking patient response over this range.*

FDA Label Image

F-3 (Sevelamer Carbonate Tablets 4)

Line graph comparing the change from baseline in phosphorus levels over 52 study weeks between Sevelamer Hydrochloride and an Active Control. The x-axis represents study weeks from 0 to 52, and the y-axis shows phosphorus change from baseline ranging from -5 to 2. Two lines with markers track changes, indicating phosphorus reduction trends for each group over time.*

FDA Label Image

10 (Sevelamer Carbonate Tablets 5)

Sevelamer Carbonate Tablets 800 mg film-coated oral tablets packaging label showing 90 tablets per container. The label includes the active ingredient Sevelamer carbonate 800 mg per tablet, inactive ingredients, storage instructions, and manufacturer Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad, India, with distribution by Amneal Pharmaceuticals LLC, Bridgewater, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.